These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 26111483

  • 1. Galectin-3 Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders and Transformed Mycosis Fungoides.
    Mitteldorf C, Robson A, Tronnier M, Pfaltz MC, Kempf W.
    Dermatology; 2015; 231(2):164-70. PubMed ID: 26111483
    [Abstract] [Full Text] [Related]

  • 2. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?
    Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA.
    Virchows Arch; 2021 Aug; 479(2):377-383. PubMed ID: 33604757
    [Abstract] [Full Text] [Related]

  • 3. Multiple cutaneous lymphoproliferative disorders showing a retained tumor clone by T-cell receptor gene rearrangement analysis: a case series of four patients and review of the literature.
    Stowman AM, Hsia LL, Kanner WA, Mahadevan MS, Bullock GC, Patterson JW.
    Int J Dermatol; 2016 Feb; 55(2):e62-71. PubMed ID: 26266670
    [Abstract] [Full Text] [Related]

  • 4. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
    Sanka RK, Eagle RC, Wojno TH, Neufeld KR, Grossniklaus HE.
    Ophthalmology; 2010 Feb; 117(2):343-51. PubMed ID: 19969358
    [Abstract] [Full Text] [Related]

  • 5. Primary cutaneous CD30(+) lymphoproliferative disorders.
    Wieser I, Tetzlaff MT, Torres Cabala CA, Duvic M.
    J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mycosis Fungoides Associated With Lesions in the Spectrum of Primary Cutaneous CD30+ Lymphoproliferative Disorders: The Same Process or 3 Coexisting Lymphomas?
    Cieza-Díaz DE, Prieto-Torres L, Rodríguez-Pinilla SM, Córdoba Mascuñano R, Manso Alonso R, Machan S, Piris Pinilla MÁ, Requena Caballero L.
    Am J Dermatopathol; 2019 Nov; 41(11):846-850. PubMed ID: 30946099
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
    Wada DA, Law ME, Hsi ED, Dicaudo DJ, Ma L, Lim MS, Souza Ad, Comfere NI, Weenig RH, Macon WR, Erickson LA, Ozsan N, Ansell SM, Dogan A, Feldman AL.
    Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Primary cutaneous lymphoma-a case series of 163 patients].
    Nashan D, Friedrich CM, Geissler E, Schmitt-Graeff A, Klein F, Meiss F.
    Hautarzt; 2018 Dec; 69(12):1014-1020. PubMed ID: 29881891
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil.
    Ferreira CR, Zhao S, Sanches JA, Miyashiro D, Cury-Martins J, Azevedo RS, Zerbini MCN, Natkunam Y, Gratzinger D.
    Diagn Pathol; 2019 Oct 22; 14(1):115. PubMed ID: 31640798
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH, Olson LC, Magro CM.
    Ann Diagn Pathol; 2017 Jun 22; 28():54-59. PubMed ID: 28648940
    [Abstract] [Full Text] [Related]

  • 15. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
    Eberle FC, Song JY, Xi L, Raffeld M, Harris NL, Wilson WH, Pittaluga S, Jaffe ES.
    Am J Surg Pathol; 2012 May 22; 36(5):716-25. PubMed ID: 22367293
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fascin expression in CD30-positive cutaneous lymphoproliferative disorders.
    Kempf W, Levi E, Kamarashev J, Kutzner H, Pfeifer W, Petrogiannis-Haliotis T, Burg G, Kadin ME.
    J Cutan Pathol; 2002 May 22; 29(5):295-300. PubMed ID: 12100631
    [Abstract] [Full Text] [Related]

  • 18. Phase I/II clinical trial of brentuximab vedotin for pretreated Japanese patients with CD30-positive cutaneous T-cell lymphoma.
    Hirai Y, Sakurai J, Yoshida S, Kikuchi T, Mitsuhashi T, Miyake T, Fujimura T, Abe R, Fujikawa H, Boki H, Suga H, Shibata S, Miyagaki T, Shimauchi T, Kiyohara E, Kawakami Y, Morizane S.
    J Dermatol; 2024 Aug 22; 51(8):1037-1049. PubMed ID: 38874430
    [Abstract] [Full Text] [Related]

  • 19. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
    Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC.
    J Cutan Pathol; 2023 Aug 22; 50(8):711-716. PubMed ID: 36944579
    [Abstract] [Full Text] [Related]

  • 20. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides.
    Simo OC, Warren SJ, Mark L, Hoffmann K, Alomari AK.
    Int J Dermatol; 2019 Jul 22; 58(7):800-805. PubMed ID: 30520526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.